Skip to main content
. Author manuscript; available in PMC: 2020 Sep 1.
Published in final edited form as: Immunol Rev. 2019 Sep;291(1):190–213. doi: 10.1111/imr.12792

Figure 1.

Figure 1

A simplified schematic of BCR signaling in lymphoma depicting genes frequently targeted for gain-of-function (red) or loss-of-function (green) genetic alterations. Percentages are estimate of frequency in all DLBCL subtypes. Frequencies include mutation and copy number alterations. Data are derived from ref. (37).